QS Investors LLC Has $4.34 Million Position in Bruker (BRKR)

QS Investors LLC lifted its position in shares of Bruker (NASDAQ:BRKR) by 115.8% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 126,546 shares of the medical research company’s stock after buying an additional 67,910 shares during the quarter. QS Investors LLC owned approximately 0.08% of Bruker worth $4,343,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in BRKR. Zions Bancorporation purchased a new position in shares of Bruker during the 3rd quarter valued at $119,000. Bank of Montreal Can lifted its stake in shares of Bruker by 346.7% during the 4th quarter. Bank of Montreal Can now owns 3,708 shares of the medical research company’s stock valued at $128,000 after buying an additional 2,878 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in Bruker by 7.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 5,003 shares of the medical research company’s stock worth $144,000 after purchasing an additional 331 shares in the last quarter. SG Americas Securities LLC purchased a new stake in Bruker in the 4th quarter worth $145,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Bruker by 43.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,586 shares of the medical research company’s stock worth $226,000 after purchasing an additional 1,987 shares in the last quarter. Institutional investors own 65.28% of the company’s stock.

How to Become a New Pot Stock Millionaire

NASDAQ:BRKR traded down $1.12 during mid-day trading on Friday, hitting $29.12. 640,342 shares of the stock traded hands, compared to its average volume of 588,352. The company has a market capitalization of $4,717.64, a price-to-earnings ratio of 24.07, a PEG ratio of 2.01 and a beta of 1.12. Bruker has a 52 week low of $21.83 and a 52 week high of $36.53. The company has a current ratio of 2.59, a quick ratio of 1.66 and a debt-to-equity ratio of 0.57.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, February 8th. The medical research company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.49 by $0.02. The company had revenue of $530.50 million for the quarter, compared to the consensus estimate of $506.74 million. Bruker had a net margin of 4.45% and a return on equity of 26.68%. The firm’s revenue was up 12.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.46 EPS. equities analysts forecast that Bruker will post 1.37 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, March 23rd. Shareholders of record on Tuesday, March 6th were paid a $0.04 dividend. The ex-dividend date was Monday, March 5th. This represents a $0.16 dividend on an annualized basis and a yield of 0.55%. Bruker’s dividend payout ratio is currently 13.22%.

Several brokerages have commented on BRKR. BidaskClub upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research note on Friday. Morgan Stanley decreased their price target on shares of Bruker from $35.00 to $32.00 and set an “equal weight” rating on the stock in a research note on Friday, February 9th. Leerink Swann boosted their price target on shares of Bruker from $32.00 to $34.00 and gave the stock a “market perform” rating in a research note on Friday, February 9th. Zacks Investment Research downgraded shares of Bruker from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Finally, BTIG Research began coverage on shares of Bruker in a report on Friday, January 5th. They issued a “buy” rating and a $42.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $32.62.

ILLEGAL ACTIVITY NOTICE: “QS Investors LLC Has $4.34 Million Position in Bruker (BRKR)” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/07/qs-investors-llc-has-4-34-million-position-in-bruker-co-brkr.html.

About Bruker

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions.

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply